Perspective Therapeutics, Inc. CATX

Set alert

Price alert · CATX

All alert types
1.15 USD -0.02 -1.71%

At close · Oct 30

1.14 -0.01 -0.87%

After hours · Oct 30, 5:53 PM ET

Bid
1.13 × 2,500
Ask
1.14 × 4,500
1.09 Day range 1.15
1.15 52-week range 5.65
YTD
-58.18%
1 year
-56.44%
Open
1.12
Prev close
1.17
Mkt cap
131.27M
Vol
2.31M
Avg vol
2.02M
EPS
-1.33
P/E
0.00
Div yield
0.00%
More statistics
Low
1.09
High
1.15
Forward P/E
-2.91
Beta
1.47
Short ratio
4.69
Inst. own
81.43%
Dividend
0.00
Ex-div date
50-d avg
7.97
200-d avg
12.20
1y target
16.15

5D chart

Chart tools
Interval

Signals (56)
NameTimeAgo
RSI: OverboughtOct 30, 4:00 PM2 days ago
MACD: Buy SignalOct 30, 3:10 PM2 days ago
MACD: Sell SignalOct 30, 2:55 PM2 days ago
MACD: Buy SignalOct 30, 2:45 PM2 days ago
MACD: Sell SignalOct 30, 2:30 PM2 days ago
MACD: Buy SignalOct 30, 2:25 PM2 days ago
MACD: Sell SignalOct 30, 2:10 PM2 days ago
RSI: OversoldOct 30, 11:30 AM2 days ago
MACD: Buy SignalOct 30, 10:40 AM2 days ago
RSI: OversoldOct 29, 3:55 PM3 days ago
MACD: Sell SignalOct 29, 3:25 PM3 days ago
MACD: Buy SignalOct 29, 3:10 PM3 days ago
MACD: Sell SignalOct 29, 1:50 PM3 days ago
RSI: OversoldOct 29, 1:50 PM3 days ago
MACD: Buy SignalOct 29, 12:35 PM3 days ago
SMA: BearishOct 29, 10:45 AM3 days ago
SMA: BearishOct 29, 10:25 AM3 days ago
MACD: Sell SignalOct 29, 10:25 AM3 days ago
MACD: Buy SignalOct 28, 3:40 PM4 days ago
SMA: BullishOct 28, 3:30 PM4 days ago
SMA: BullishOct 28, 3:30 PM4 days ago
MACD: Sell SignalOct 28, 2:25 PM4 days ago
RSI: OverboughtOct 28, 1:40 PM4 days ago
SMA: BullishOct 28, 12:40 PM4 days ago
SMA: BearishOct 28, 12:35 PM4 days ago
SMA: BearishOct 28, 11:35 AM4 days ago
MACD: Buy SignalOct 28, 11:10 AM4 days ago
RSI: OversoldOct 28, 10:25 AM4 days ago
SMA: BearishOct 28, 10:10 AM4 days ago
MACD: Sell SignalOct 28, 10:10 AM4 days ago
SMA: BullishOct 28, 10:05 AM4 days ago
SMA: BullishOct 28, 10:05 AM4 days ago
MACD: Buy SignalOct 28, 10:05 AM4 days ago
SMA: BearishOct 28, 10:00 AM4 days ago
SMA: BullishOct 28, 9:55 AM4 days ago
SMA: BullishOct 27, 2:30 PM5 days ago
SMA: BearishOct 27, 2:25 PM5 days ago
SMA: BearishOct 27, 2:10 PM5 days ago
SMA: BullishOct 27, 2:05 PM5 days ago
MACD: Sell SignalOct 27, 1:50 PM5 days ago
MACD: Buy SignalOct 27, 1:40 PM5 days ago
MACD: Sell SignalOct 27, 1:35 PM5 days ago
RSI: OverboughtOct 27, 12:30 PM5 days ago
SMA: BearishOct 27, 11:35 AM5 days ago
SMA: BullishOct 27, 11:30 AM5 days ago
SMA: BearishOct 27, 11:15 AM5 days ago
MACD: Buy SignalOct 27, 10:45 AM5 days ago
RSI: OversoldOct 27, 9:50 AM5 days ago
RSI: OversoldOct 27, 9:40 AM5 days ago
MACD: Sell SignalOct 26, 3:25 PM6 days ago
SMA: BearishOct 26, 2:10 PM6 days ago
SMA: BullishOct 26, 2:05 PM6 days ago
MACD: Buy SignalOct 26, 1:50 PM6 days ago
MACD: Sell SignalOct 26, 1:40 PM6 days ago
SMA: BearishOct 26, 12:00 PM6 days ago
SMA: BullishOct 26, 11:10 AM6 days ago

Financial health

Altman Z-Score

-0.50 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -2.0×
FY 2016: -56.8×FY 2017: -37.5×FY 2018: -56.7×FY 2019: -115×FY 2020: -137×FY 2021: -6.2×FY 2022: -4.1×FY 2023: -4.7×FY 2024: -2.6×FY 2025: -2.0×
FY 2016 5y median -4.1× FY 2025
P/S 0.0×
FY 2016: 72.2×FY 2017: 41.9×FY 2018: 37.6×FY 2019: 38.8×FY 2020: 43.6×FY 2021: 4.1×FY 2022: 8.2×FY 2023: 154×FY 2024: 141×FY 2025: 0.0×
FY 2016 5y median 8.2× FY 2025
P/B 1.0×
FY 2016: 32.4×FY 2017: 49.3×FY 2018: 35.8×FY 2019: 65.7×FY 2020: 34.3×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 2.9×FY 2024: 0.7×FY 2025: 1.0×
FY 2016 5y median 0.8× FY 2025
P/FCF -2.1×
FY 2016: -54.9×FY 2017: -41.0×FY 2018: -50.0×FY 2019: -96.0×FY 2020: -136×FY 2021: -5.5×FY 2022: -4.2×FY 2023: -5.8×FY 2024: -2.8×FY 2025: -2.1×
FY 2016 5y median -4.2× FY 2025
EV/EBITDA -1.7×
FY 2016: -54.6×FY 2017: -36.7×FY 2018: -52.4×FY 2019: -108×FY 2020: -131×FY 2021: 1.6×FY 2022: -2.8×FY 2023: -5.4×FY 2024: -2.3×FY 2025: -1.7×
FY 2016 5y median -2.3× FY 2025
EV/Sales 0.0×
FY 2016: 71.0×FY 2017: 41.5×FY 2018: 36.9×FY 2019: 38.7×FY 2020: 42.7×FY 2021: -1.1×FY 2022: 4.4×FY 2023: 149×FY 2024: 102×FY 2025: 0.0×
FY 2016 5y median 4.4× FY 2025
FCF Yield -46.9%
FY 2016: -1.8%FY 2017: -2.4%FY 2018: -2.0%FY 2019: -1.0%FY 2020: -0.7%FY 2021: -18.2%FY 2022: -24.0%FY 2023: -17.2%FY 2024: -35.4%FY 2025: -46.9%
FY 2016 5y median -24.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 17.6%FY 2017: 31.1%FY 2018: 41.7%FY 2019: 52.9%FY 2020: 50.9%FY 2021: 42.8%FY 2022: 43.7%FY 2023: 100.0%FY 2024: -58.6%FY 2025: 0.0%
FY 2016 5y median 42.8% FY 2025
Operating Margin 0.0%
FY 2016: -132.5%FY 2017: -113.6%FY 2018: -72.2%FY 2019: -35.9%FY 2020: -34.2%FY 2021: -68.5%FY 2022: -168.1%FY 2023: -2855.0%FY 2024: -4594.0%FY 2025: 0.0%
FY 2016 5y median -168.1% FY 2025
Net Margin 0.0%
FY 2016: -129.4%FY 2017: -113.1%FY 2018: -66.3%FY 2019: -33.8%FY 2020: -31.7%FY 2021: -67.4%FY 2022: -198.7%FY 2023: -3243.2%FY 2024: -5452.5%FY 2025: 0.0%
FY 2016 5y median -198.7% FY 2025
ROE -49.8%
FY 2016: -58.1%FY 2017: -133.2%FY 2018: -63.2%FY 2019: -57.1%FY 2020: -25.0%FY 2021: -11.9%FY 2022: -19.7%FY 2023: -61.9%FY 2024: -27.3%FY 2025: -49.8%
FY 2016 5y median -27.3% FY 2025
ROIC -47.2%
FY 2016: -55.2%FY 2017: -119.2%FY 2018: -59.9%FY 2019: -44.8%FY 2020: -22.4%FY 2021: -11.8%FY 2022: -16.5%FY 2023: -46.4%FY 2024: -20.1%FY 2025: -47.2%
FY 2016 5y median -20.1% FY 2025
ROA -38.6%
FY 2016: -50.2%FY 2017: -89.9%FY 2018: -51.5%FY 2019: -37.6%FY 2020: -20.6%FY 2021: -11.3%FY 2022: -18.5%FY 2023: -47.5%FY 2024: -23.2%FY 2025: -38.6%
FY 2016 5y median -23.2% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: -0.2%FY 2017: 24.4%FY 2018: 23.5%FY 2019: 32.3%FY 2020: 3.9%FY 2021: 7.4%FY 2022: -49.8%FY 2023: -73.5%FY 2024: 1.4%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -70.0%
FY 2016: -24.1%FY 2017: -6.7%FY 2018: 21.6%FY 2019: 34.1%FY 2020: 1.1%FY 2021: -115.0%FY 2022: -23.2%FY 2023: -349.8%FY 2024: -63.2%FY 2025: -70.0%
FY 2016 FY 2025
EPS (diluted) -13.8%
FY 2016: -28.5%FY 2017: -9.1%FY 2018: 39.8%FY 2019: 33.1%FY 2020: -20.0%FY 2021: -760.6%FY 2022: -20.0%FY 2023: -41.7%FY 2024: -44.7%FY 2025: -13.8%
FY 2016 FY 2025
Free Cash Flow -31.0%
FY 2016: -43.5%FY 2017: 3.4%FY 2018: 9.2%FY 2019: 28.7%FY 2020: 17.8%FY 2021: -147.9%FY 2022: -33.9%FY 2023: -255.6%FY 2024: -91.4%FY 2025: -31.0%
FY 2016 FY 2025

Financial Health

Current Ratio 5.2×
FY 2016: 9.3×FY 2017: 3.0×FY 2018: 6.5×FY 2019: 3.5×FY 2020: 9.2×FY 2021: 26.2×FY 2022: 17.1×FY 2023: 1.1×FY 2024: 12.7×FY 2025: 5.2×
FY 2016 5y median 12.7× FY 2025
Quick Ratio 5.2×
FY 2016: 9.0×FY 2017: 2.7×FY 2018: 6.1×FY 2019: 3.1×FY 2020: 8.7×FY 2021: 25.6×FY 2022: 16.6×FY 2023: 1.1×FY 2024: 12.7×FY 2025: 5.2×
FY 2016 5y median 12.7× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 1.0×FY 2017: 0.4×FY 2018: 1.0×FY 2019: 0.4×FY 2020: 2.6×FY 2021: 7.8×FY 2022: 2.4×FY 2023: 0.2×FY 2024: 0.9×FY 2025: 0.3×
FY 2016 5y median 0.9× FY 2025
Interest Coverage -302×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -487×FY 2024: -1392×FY 2025: -302×
FY 2016 5y median -302× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -0.2%FY 2017: -0.2%FY 2018: -0.2%FY 2019: -0.3%FY 2020: -0.3%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31